Literature DB >> 22762522

Intrahippocampal transplantation of mesenchymal stromal cells promotes neuroplasticity.

Nicolas Coquery1, Armin Blesch, Albrecht Stroh, Francisco Fernández-Klett, Julia Klein, Christine Winter, Josef Priller.   

Abstract

BACKGROUND AIMS: Multipotent mesenchymal stromal cells (MSC) secrete soluble factors that stimulate the surrounding microenvironment. Such paracrine effects might underlie the potential benefits of many stem cell therapies. We tested the hypothesis that MSC are able to enhance intrinsic cellular plasticity in the adult rat hippocampus.
METHODS: Rat bone marrow-derived MSC were labeled with very small superparamagnetic iron oxide particles (VSOP), which allowed for non-invasive graft localization by magnetic resonance imaging (MRI). Moreover, MSC were transduced with lentiviral vectors to express the green fluorescent protein (GFP). The effects of bilateral MSC transplantation on hippocampal cellular plasticity were assessed using the thymidine analogs 5-bromo-2'-deoxyuridine (BrdU) and 5-iodo-2'-deoxyuridine (IdU). Behavioral testing was performed to examine the consequences of intrahippocampal MSC transplantation on locomotion, learning and memory, and anxiety-like and depression-like behavior.
RESULTS: We found that intrahippocampal transplantation of MSC resulted in enhanced neurogenesis despite short-term graft survival. In contrast, systemic administration of the selective serotonin re-uptake inhibitor citalopram increased cell survival but did not affect cell proliferation. Intrahippocampal transplantation of MSC did not impair behavioral functions in rats, but only citalopram exerted anti-depressant effects.
CONCLUSIONS: This is the first study to examine the effects of intrahippocampal transplantation of allogeneic MSC on hippocampal structural plasticity and behavioral functions in rats combined with non-invasive cell tracking by MRI. We found that iron oxide nanoparticles can be used to detect transplanted MSC in the brain. Although graft survival was short, intrahippocampal transplantation of MSC resulted in long-term changes in hippocampal plasticity. Our results suggest that MSC can be used to stimulate adult neurogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22762522     DOI: 10.3109/14653249.2012.694418

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  13 in total

1.  GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer's disease model.

Authors:  Dong Hyun Kim; Dahm Lee; Eun Hyuk Chang; Ji Hyun Kim; Jung Won Hwang; Ju-Yeon Kim; Jae Won Kyung; Sung Hyun Kim; Jeong Su Oh; Sang Mi Shim; Duk Lyul Na; Wonil Oh; Jong Wook Chang
Journal:  Stem Cells Dev       Date:  2015-08-19       Impact factor: 3.272

2.  Mesenchymal stem cells can prevent alterations in behavior and neurogenesis induced by Aß25-35 administration.

Authors:  Keren Nicole Hamisha; Matanel Tfilin; Joseph Yanai; Gadi Turgeman
Journal:  J Mol Neurosci       Date:  2014-11-12       Impact factor: 3.444

3.  Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory function when cultured in spheroids.

Authors:  Jürgen Berg; Manfred Roch; Jennifer Altschüler; Christine Winter; Anne Schwerk; Andreas Kurtz; Barbara Steiner
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

Review 4.  Immune-based strategies for mood disorders: facts and challenges.

Authors:  Gabriela D Colpo; Marion Leboyer; Robert Dantzer; Mahdukar H Trivedi; Antonio L Teixeira
Journal:  Expert Rev Neurother       Date:  2017-11-27       Impact factor: 4.618

Review 5.  Mechanisms supporting potential use of bone marrow-derived mesenchymal stem cells in psychocardiology.

Authors:  Jianyang Liu; Lijun Zhang; Meiyan Liu
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

6.  Therapeutic effect of placenta-derived mesenchymal stem cells on hypoxic-ischemic brain damage in rats.

Authors:  Hong-Fang Ding; Hui Zhang; Hui-Fang Ding; Dong Li; Xin-Hao Yi; Xin-Yi Gao; Wei-Wei Mou; Xiu-Li Ju
Journal:  World J Pediatr       Date:  2014-12-01       Impact factor: 2.764

7.  Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats.

Authors:  Kyohei Kin; Takao Yasuhara; Masahiro Kameda; Yousuke Tomita; Michiari Umakoshi; Ken Kuwahara; Ittetsu Kin; Naoya Kidani; Jun Morimoto; Mihoko Okazaki; Tatsuya Sasaki; Naoki Tajiri; Cesario V Borlongan; Isao Date
Journal:  Mol Psychiatry       Date:  2018-08-14       Impact factor: 15.992

8.  Therapeutic Effect of Astroglia-like Mesenchymal Stem Cells Expressing Glutamate Transporter in a Genetic Rat Model of Depression.

Authors:  Amit Shwartz; Oshra Betzer; Noam Kronfeld; Gila Kazimirsky; Simona Cazacu; Susan Finniss; Hae Kyung Lee; Menachem Motiei; Shani Yael Dagan; Rachela Popovtzer; Chaya Brodie; Gal Yadid
Journal:  Theranostics       Date:  2017-07-06       Impact factor: 11.556

9.  Transplantation of mesenchymal stem cells reverses behavioural deficits and impaired neurogenesis caused by prenatal exposure to valproic acid.

Authors:  Nikolai Gobshtis; Matanel Tfilin; Marina Wolfson; Vadim E Fraifeld; Gadi Turgeman
Journal:  Oncotarget       Date:  2017-03-14

10.  Transplantation of mesenchymal stem cells causes long-term alleviation of schizophrenia-like behaviour coupled with increased neurogenesis.

Authors:  Nikolai Gobshtis; Matanel Tfilin; Vadim E Fraifeld; Gadi Turgeman
Journal:  Mol Psychiatry       Date:  2019-12-11       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.